Don't Laser First: How Doctors Tell Melasma From Hyperpigmentation
Melasma is a specific, chronic subtype of hyperpigmentation, not a synonym for it. It typically shows up as symmetric, hormonally linked facial patches, while the broader category of hyperpigmentation includes sunspots and injury-related marks that behave very differently. Getting the diagnosis wrong matters: procedures that clear an ordinary dark spot can flare melasma or trigger new pigment. The rest of this guide walks through how clinicians tell them apart and how treatment strategy shifts once they do.
TL;DR:
- Melasma typically presents as symmetric, grey-brown patches on the cheeks, forehead, upper lip, and jawline, with patterns including centrofacial, malar, and mandibular cases.
- Differential diagnosis relies on pattern recognition, Wood lamp testing, dermoscopy, detailed history, and biopsy if lesions change rapidly or don’t respond to treatment.
- Sunlight, hormonal shifts, inflammation, and photosensitizing medications are primary triggers for melasma, with UV and visible light playing significant roles in its recurrence.
- Effective treatment involves a combination of topical tyrosinase inhibitors, strict photoprotection with tinted sunscreens, and cautious use of procedures like laser or peels, with maintenance therapy for long-term control.
- Patience is essential, as melasma is chronic and prone to relapse; professional evaluation is recommended if patches change or persist despite several months of treatment.
Table of Contents
- What Is Hyperpigmentation? The Umbrella Term and Common Subtypes
- What Is Melasma? Presentation, Pattern, and Why It’s Distinct
- How Do Doctors Tell Melasma Apart From Other Hyperpigmentation?
- Causes and Common Triggers: Sunlight, Hormones, Inflammation, and Medications
- Treatment Options and Risks: What Works and What Can Backfire
- Sun Protection and Visible-Light Mitigation
- Managing Expectations: Prognosis, Relapse, and When to See a Specialist
- Cellure’s Approach to Safe, Evidence-Based Pigment Care
- What I’d Tell a Friend Asking About This
- Sources
What Is Hyperpigmentation? The Umbrella Term and Common Subtypes
Hyperpigmentation is a broad, descriptive term for any patch of skin that has darkened because of excess melanin, the pigment cells produce. It’s not a diagnosis on its own. It’s a symptom that shows up across several distinct skin conditions, each with its own trigger, depth, and treatment response.
The subtypes clinicians see most often include:
- Post-inflammatory hyperpigmentation (PIH): dark marks left behind after acne, eczema, a cut, or a laser treatment. These follow the shape of the original injury, not a symmetric facial pattern.
- Solar lentigines (sun spots or “age spots”): flat, well-defined brown spots on chronically sun-exposed skin like the hands, chest, and face. They persist until treated and tend to respond well to lasers and IPL, unlike melasma.
- Drug-induced pigmentation: darkening triggered by medications such as certain antibiotics, chemotherapy agents, or amiodarone, sometimes with unusual gray or slate coloring.
- Nevus and birthmark-related pigmentation: localized pigmented lesions like café-au-lait macules or acquired nevi, which are structurally different from diffuse pigment disorders.
- Melasma: the chronic, hormonally influenced pattern covered in detail below.
What separates these clinically is how they respond to treatment. Post-inflammatory hyperpigmentation usually fades on its own once the underlying inflammation is controlled, and it responds well to topical brightening agents. Solar lentigines are stubborn to creams but often clear in one or two laser sessions. Melasma sits at the difficult end of the spectrum: it responds to treatment, then often returns. That single fact drives almost every decision a dermatologist makes about how aggressively to intervene.
What Is Melasma? Presentation, Pattern, and Why It’s Distinct
Melasma shows up as symmetric brown-to-gray patches, most often across the cheeks, forehead, upper lip, and jawline. It’s this symmetry, more than the color itself, that separates melasma from other pigmentation disorders. A dermatologist looking at a face with matching patches on both cheeks is already thinking about melasma before ever asking a single question.
The distribution tends to fall into recognizable patterns:
- Centrofacial: forehead, nose, cheeks, and upper lip, the most common presentation.
- Malar: cheeks and nose only.
- Mandibular: jawline, less common and sometimes linked to more sun exposure over time.
Color varies with depth. Epidermal melasma, where pigment sits in the upper skin layers, tends to look light to medium brown and often responds better to topical treatment. Dermal melasma, where melanin has been deposited deeper by pigment-carrying immune cells, appears blue-gray and resists lightening creams far more stubbornly. Many patients have a mixed pattern, which is part of why treatment often needs to combine approaches rather than rely on one product.
Melasma has strong hormonal ties. Pregnancy (“the mask of pregnancy,” or chloasma), oral contraceptives, and hormone replacement therapy are established triggers, and genetics loads the gun. Melasma pathogenesis involves UV and visible light, hormones, genetics, and vascular and dermal factors working together rather than any single cause acting alone. That combination explains why melasma is chronic and relapsing in a way that most other pigmentation issues simply aren’t. A sunspot, once removed, tends to stay gone. Melasma, once controlled, tends to come back the next time hormones shift or sun exposure spikes.
How Do Doctors Tell Melasma Apart From Other Hyperpigmentation?
Diagnosis starts with the eyes, but it doesn’t end there. A clinician evaluating facial pigmentation typically works through a short sequence of checks before naming a condition and choosing a treatment plan.
- Look at the pattern and symmetry. Melasma is almost always bilateral and symmetric. PIH follows the outline of whatever caused it, an old acne cyst, a healed cut, a laser burn, so it’s usually irregular and one-sided or scattered.
- Use a Wood lamp. This ultraviolet light tool helps distinguish epidermal pigment (which fluoresces and appears more visible under the lamp) from dermal pigment (which shows little change). It’s a quick office test, though it’s less reliable on darker skin tones where contrast is harder to read.
- Check with dermoscopy. A handheld magnifier with polarized light lets a clinician examine pigment network patterns and vascular structures, useful for catching solar lentigines or early skin cancers that can mimic pigmentation disorders.
- Take a detailed history. Pregnancy, birth control or hormone therapy, thyroid disease, recent chemical peels or laser sessions, and any new medications all factor into the diagnosis.
- Biopsy when something doesn’t fit. If a patch has irregular borders, changes rapidly, or doesn’t respond to standard therapy, a specialist review or biopsy rules out melanocytic lesions or other skin conditions that need different management entirely.
Pro Tip: Bring a timeline to your dermatology visit. Note when the spots appeared, whether you were pregnant or started a new medication around that time, and whether the patches are symmetric. That single piece of history often narrows the diagnosis faster than any in-office test.
Red flags that call for urgent evaluation include a rapidly darkening or asymmetric lesion, one with irregular borders or multiple colors, or any patch that bleeds or changes texture. Those findings point away from routine pigmentation and toward something that needs a dermatologist’s eyes right away.
Causes and Common Triggers: Sunlight, Hormones, Inflammation, and Medications
Every pigmentation disorder traces back to one of a handful of triggers, and most patients have more than one at play.
- UV and visible light. Ultraviolet radiation is the obvious driver, but high-energy visible light, the kind emitted by the sun and, to a lesser degree, screens, also contributes to melasma recurrence. This is why standard SPF alone often isn’t enough for melasma-prone skin.
- Hormonal shifts. Pregnancy, oral contraceptives, and hormone replacement therapy are the classic triggers for melasma specifically. Thyroid disease has also been linked in some patients, which is part of why a thorough history matters.
- Inflammation. Acne, eczema, psoriasis, and even aggressive extractions or peels can trigger PIH as skin heals. The more inflamed the initial injury, the darker the resulting mark tends to be, especially in deeper skin tones.
- Photosensitizing medications and tanning beds. Certain antibiotics, retinoids, and other drugs increase sun sensitivity and can worsen any existing pigmentation. Tanning beds compound the same UV and visible-light exposure that drives melasma in the first place.
Practical avoidance starts with identifying which of these apply to you. If you’re on a new medication and notice new pigment, ask your prescriber about photosensitivity. If your melasma always worsens in summer, that’s a visible-light and UV problem, not just a UV problem, and it changes what kind of sunscreen you need.
Treatment Options and Risks: What Works and What Can Backfire
Topical therapy is the starting point for nearly every pigmentation disorder, but the specific ingredients and sequencing differ once melasma is confirmed.
First-line topicals center on tyrosinase inhibitors, ingredients that block the enzyme responsible for melanin production. Hydroquinone has the longest track record and the most clinical study behind it. Newer alternatives like thiamidol and azelaic acid offer similar mechanisms with different tolerability profiles. Consensus guidance lists topical tyrosinase inhibitors and triple-combination therapy (typically a tyrosinase inhibitor, a retinoid, and a mild steroid together) as first-line for melasma specifically, because combining agents that target pigment, cell turnover, and inflammation outperforms any single ingredient alone.
Tranexamic acid has emerged as a genuine adjunct rather than a replacement for these approaches. Guideline summaries now name tranexamic acid, topical or oral, as an adjuvant for moderate-to-severe melasma when paired with other modalities. Oral use requires medical supervision because of thrombotic risk, which is why most over-the-counter formulations use the topical form. Pregnant patients should pause topical tranexamic acid use, a caution worth flagging with any provider before starting a routine.
Procedural options carry more nuance than most patients expect. Chemical peels, microneedling, and laser or IPL treatments can help, but they can also backfire. Chemical peels and lasers carry a real risk of worsening melasma or causing new post-inflammatory hyperpigmentation if the skin isn’t primed first, and that risk rises further in Fitzpatrick III to VI skin tones, where conservative settings and pretreatment priming meaningfully lower the odds of rebound pigment.
Pro Tip: Never book a laser or peel for melasma without at least two to four weeks of topical priming first. Dermatologists routinely pretreat with a tyrosinase inhibitor to calm the pigment-producing cells before introducing any heat or resurfacing device.
Sequencing matters as much as the ingredients themselves:
- Start with topical priming (tyrosinase inhibitors plus strict photoprotection) for several weeks before any procedure.
- Introduce procedural treatments gradually and only under professional guidance if melasma is confirmed.
- Layer in tranexamic acid as an adjunct once the skin tolerates the core routine.
- Maintain the routine indefinitely rather than stopping once pigment fades.
Realistic timelines matter here. Topical improvement for straightforward PIH often shows up within a few weeks. Melasma moves slower and less predictably, frequently taking multiple months of combined topical therapy and strict photoprotection to reach its best result, and even then, it needs maintenance therapy to stay controlled. A structured melasma skincare routine built around this sequencing, rather than a single “brightening serum,” gives the best odds of a result that actually holds.
Sun Protection and Visible-Light Mitigation
Every treatment plan for melasma and hyperpigmentation rests on the same foundation: consistent, comprehensive photoprotection. Skip this step and even the best topical routine underperforms.
- Use a broad-spectrum sunscreen with high SPF daily, one that covers UVA1 specifically, not just UVB. Standard SPF ratings focus on UVB protection and can miss the longer UVA wavelengths that penetrate deeper and drive melasma.
- Choose a tinted formula with iron oxides whenever melasma is part of the picture. Iron oxides physically block visible light, reducing the HEV exposure that helps trigger relapse in a way that untinted mineral or chemical sunscreens alone cannot.
- Reapply every two hours outdoors, and don’t skip cloudy days. Visible light and UVA both penetrate cloud cover more than most people assume.
- Add a physical barrier, a wide-brim hat or UPF clothing, for extended outdoor time, and layer in antioxidants like vitamin C underneath sunscreen to help manage residual oxidative stress on the skin.
Pro Tip: Keep a travel-size tinted sunscreen at your desk. Office lighting and screen exposure are minor compared to daylight through a window, but the habit of reapplying becomes automatic once the bottle is within reach.
Managing Expectations: Prognosis, Relapse, and When to See a Specialist
Patience matters more with melasma than with almost any other pigmentation issue. Expect early improvement within a few weeks of consistent topical therapy, but full results for melasma typically take months, not weeks.
The prognosis genuinely differs by type. PIH usually clears fully once the triggering inflammation is under control. Melasma tends to be chronic and relapsing even after successful treatment, which means maintenance therapy isn’t optional, it’s the plan.
See a dermatologist if:
- Pigment changes shape, color, or texture rather than simply fading and returning in the same pattern.
- Standard topical therapy shows no improvement after several months.
- You’re considering a procedural treatment and want a proper diagnosis first.
- The patches cause significant distress; camouflage makeup and psychosocial support resources can help in the meantime while treatment takes effect.
Cellure’s Approach to Safe, Evidence-Based Pigment Care
Understanding an ingredient’s mechanism is only half the job. The other half is using it safely, in the right sequence, on the right skin.
A few safety notes worth keeping in mind regardless of which routine you follow:
- Pause topical tranexamic acid during pregnancy and check with a provider before restarting postpartum.
- Patch test any new active, especially tyrosinase inhibitors and retinoids, before applying it across the full face.
- Avoid stacking multiple strong actives at once, since irritation from combining exfoliants, retinoids, and brightening agents can itself trigger new post-inflammatory pigment, working against the goal.
Cellure builds its tranexamic acid formulations around this same evidence-first logic: pair active ingredients with clear safety guidance rather than positioning any single product as a stand-alone fix. For readers managing pregnancy-related pigment changes specifically, the guidance on tranexamic acid and pregnancy walks through what to pause and what to use instead.
What I’d Tell a Friend Asking About This
The distinction between melasma and general hyperpigmentation isn’t academic. It decides whether a laser helps you or sets you back six months. My advice: review your hormone and medication history honestly, start a tinted high-SPF sunscreen today, and see a dermatologist before booking any procedure if your pigment is symmetric or keeps returning. Treat maintenance as the plan, not the afterthought.
— Sara
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Sources
- Melasma - StatPearls - NCBI Bookshelf
- Melasma - DermNet NZ
- Melanin hyperpigmentation disorders, management: guideline summary - Medscape (2026)
- Hyperpigmentation - Cleveland Clinic
- Melasma: What are the best treatments? - Harvard Health
